NLS Collaboration

The collaboration combines Salipro Biotech's expertise and its Salipro platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug discovery programs for the generation of small molecule drugs.

The University of Oxford and ReciBioPharm, Recipharm’s Advanced Biologics division are expanding their collaboration with the development of two blood-stage malaria vaccine candidates for Phase 1/2 clinical trials.

A new strategic collaboration between life science clusters from Northern Europe and the UK’s National Institute for Health and Care Research (NIHR) is set to open new pathways for companies to engage with the UK’s healthcare and research ecosystem.

Alvotech and Dr. Reddy’s Laboratories have entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets.

With the agreement, the Novo Nordisk Foundation expands its existing collaboration with WHO, committing to a granting frame of up to DKK 380 million over the next four years.

The collaboration expands upon ContextVision’s ongoing Data Quality initiative to develop AI-powered, organ-specific imaging solutions that enable MASLD screening and physiological quantification.